[Image: masthead]

24-HOUR MH HOTLINE

800-644-9737

Outside NA: 001-209-417-3722
FOR EMERGENCIES ONLY

24-HOUR MH HOTLINE: 800-644-9737
Outside NA: 001-209-417-3722
FOR EMERGENCIES ONLY

Blog

Blog

Regular updates by our President, MHAUS staff, and guest contributors.

The claims and opinions expressed in website blogs are those of the authors and not necessarily the views or opinions of MHAUS, its staff or its advertisers.

Advances in Scientific Knowledge: Lessons Learned from the Study of Malignant Hyperthermia
Dr. Henry Rosenberg, MHAUS President
April 14, 2020

The conclusions expressed in this essay and the projections for the future are mine and have not yet gone through the rigorous review process of MHAUS. 

I have focused a large component of my professional life in the study of MH and have been thinking of how my experience with this deadly disorder might be related to the issues with COVID-19.

Comments (0)
COVID-19 and MH Statement
Dr. Henry Rosenberg
March 31, 2020

Here is a statement from the MHAUS President, Dr. Henry Rosenberg, regarding COVID-19 and MH. 

Comments (0)
Coronavirus and Malignant Hyperthermia
Dr. Henry Rosenberg
March 17, 2020

This is to clarify concerns regarding potential  risks that patients who are MH susceptible might experience concerning infection with the COVID-19 virus. 

Comments (0)
A New Era in Dealing with the Malignant Hyperthermia Syndrome
Dr. Henry Rosenberg
March 10, 2020

The conclusions expressed in this essay and the projections for the future are mine and have not yet gone through the rigorous review process of MHAUS.

Comments (0)
Remembering Dr. Kevin Nolan
MHAUS
January 3, 2020

Dr. Kevin Nolan 

September 19, 1950 - December 26, 2019

Comments (0)
Resolutions for MHAUS
Dr. Henry Rosenberg
January 3, 2020

Dr. Henry Rosenberg compiled a list of New Year's Resolutions for 2020 

Comments (0)
Faces of MH
September 11, 2019

Faces of MH are stories about people who lives have been changed by Malignant Hyperthermia.

Faces of MH are stories about people who lives have been changed by Malignant Hyperthermia. Click the links below to read stories of people whose lives have been changed by Malignant Hyperthermia and to add your own. 

Views and opinions expressed on this page are that of the individual telling their story and not from MHAUS.

Comments (0)
Social Security Benefits and MH
Guest Contributor
September 3, 2019

If you have been diagnosed with Malignant Hyperthermia and you expect that you cannot work for at least 12 months because of it, you can file a claim for Social Security disability benefits.

 

Comments (0)
Emergency Therapy for MH Protocol Poster Revision Date
Dianne Daugherty, MHAUS/NMSIS Executive Director
May 3, 2019

Blurb from the Malignant Hyperthermia Association of the United States (MHAUS) regarding the 2018/2019 Emergency Therapy for MH Protocol Poster Revision Dates

 

Comments (0)
Consensus Statement of MHAUS on Unresolved Clinical Questions Concerning Management of Patients with MH
Litman, Ronald S., DO, ML; Smith, Victoria I.; Larach, Marilyn Green, MD, FAAP; Mayes, Lena, MD; Shukry, Mohanad, MD, PhD; Theroux, Mary C., MD; Watt, Stacey, MD, FASA; Wong, Cynthia A., MD
February 21, 2019

Consensus Statement of the Malignant Hyperthermia Association of the United States on Unresolved Clinical Questions Concerning the Management of Patients With Malignant Hyperthermia 

An Abstract from Anesthesia & Analgesia 

Comments (0)
Looking Back and Looking Forward
Dr. Henry Rosenberg
January 14, 2019
  Looking Back and Looking Forward    2019 marks the 38th year since the formation of the Malignant Hyperthermia Association of the United States. The vision of the founders of MHAUS seemed grandiose at the time, but the accomplishments have been truly remarkable. To enumerate all the activities and programs …
Comments (0)
Honoring the Life of Professor Frank Lehmann-Horn
Guest Contributor
June 18, 2018
Open channels – The life of Prof. Dr. Dr. h.c. Dipl. Ing. Frank Lehmann-Horn   Prof. Dr. Dr. h.c. Dipl. Ing. Frank Lehmann-Horn, director of the department of applied physiology at Ulm university Germany from 1992 to 2010, passed away on May 8th, 2018 after suffering a severe disease …
Comments (0)
Heat and Exercise Induced Injury - Daniel Massik Essay Contest
MHAUS
March 22, 2018

The Malignant Hyperthermia Association of the United States (MHAUS) is pleased to announce the establishment of an award in the amount $1,500 to the primary author of a manuscript related to heat stroke or exercise-induced heat injury. 

Comments (0)
MH Readiness Feedback from Multiple Facilities
Dianne Daugherty, MHAUS Executive Director
April 17, 2017
The only requirement the Malignant Hyperthermia Association of the United States (MHAUS) will not waiver on is this:  Any facility using a trigger for malignant hyperthermia (potent volatile anesthetics and/or succinylcholine) must assure there is a sufficient supply of dantrolene sodium for injection available within 10 minutes, in whatever form …
Comments (1)
Long-term Sequelae In Patients Who Experienced a Malignant Hyperthermia Event
MHAUS Staff
December 13, 2016
Werneid K, Riazi S, Brandom BW. Presented to the International Anesthesia Research Society (IARS) 2015 In the article Survey of Long-Term Sequelae in Survivors of a Malignant Hyperthermia Reaction, 23 people responded to a survey asking about the symptoms they experienced after an MH event. The most commonly reported symptoms …
Comments (5)
Unexpected MH Deaths Without Exposure To Inhalation Anesthetics In Pediatric Patients
MHAUS Staff
December 13, 2016
Brandom, BW, & Muldoon, SM. Paediatric Anaesthesia. September 2013.It is well documented that infants, children and adolescents with certain gene mutations are susceptible to malignant hyperthermia when exposed to certain medications including succinylcholine, a muscle relaxant, and inhalation anesthetics. However, fatal, MH-like episodes have also been documented in children not …
Comments (4)
Temperature changes are not late signs of malignant hyperthermia: A NAMH Registry of MHAUS Study
Guest Contributor
December 13, 2016
Temperature changes are not late signs of malignant hyperthermia: A NAMH Registry of MHAUS Study. Larach MG, Allen GC, Brandom BW, Gronert GA, & Lehman EB. Presented to the American Society of Anesthesiologists (ASA), 2008Malignant hyperthermia poses a significant risk to affected patients. Despite modern treatment and increased availability and …
Comments (2)
Is there a link between malignant hyperthermia and exertional heat illness?
Guest Contributor
December 13, 2016
Muldoon SM, Deuster P, Brandom BW, Bunger R. Exercise and Sport Sciences Reviews, 2004It has been suggested that people who have experienced an episode of exertional heat illness may be more prone to malignant hyperthermia and vice versa due to a similar genetic mutation. Malignant hyperthermia (MH) is an anesthetic …
Comments (2)
Intraoperative Presentation of MH Leads To KD Syndrome Diagnosis
MHAUS Staff
December 8, 2016
Abstract: We present the novel case report of a child with hypotonia and dysmorphic features who developed malignant hyperthermia (MH) intraoperatively. Neurology workup revealed the presence of a known causative ryanodine receptor (RYR1) mutation for MH, c.7522C>T; p.R2508C. Furthermore, the neurology workup diagnosed the child with King-Denborough syndrome (KDS). This …
Comments (0)
Long Term Oral Dantrolene Improved Muscular Symptoms in a Malignant Hyperthermia Susceptible Individual
Guest Contributor
November 17, 2016
Long term oral Dantrolene Improved Muscular Symptoms in a Malignant Hyperthermia Susceptible Individual. Butala, BN, Kang, A, Guron, J, & Brandom, BW. Journal of Neuromuscular Diseases, 2016. Dantrolene is a medication used for the treatment of acute malignant hyperthermia (MH) events as well as for chronic muscle spasms in some …
Comments (0)
The mission of MHAUS is to promote optimum care and
scientific understanding of MH and related disorders.